s6y
Company name or ticker
Search
MoonLake Immunotherapeutics
4
BIOTECHNOLOGY VALUE FUND L P: Statement of changes in beneficial ownership of securities
Filed
Monday, June 22, 2026
Period
Jun 17, 2026
Accession number
0000921895-26-001639
Documents
OWNERSHIP DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header